Rucaparib

Red

Brand Name(s):Rubraca

Indication:Cancer – Maintenance treatment of epithelial ovarian, fallopian tube, or primary peritoneal (monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed high-grade)

Adult patients (monotherapy treatment) with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy.

Rationale:1,2,3

Considered:Apr-19

Review Date:Apr-24

Comments: